LL-37

Community Q&A

What is LL-37 used for?

Community accounts on LL-37 cluster around two main use cases: chronic infection resistant to standard treatment, and wound healing. Accounts from users managing recurring infections — sinusitis, biofilm-related conditions, Lyme-related symptoms — appear most frequently. Wound healing accounts describe LL-37 accelerating healing in wounds that had stalled. LL-37 accounts are disproportionately from users with complex or treatment-resistant conditions rather than general wellness optimisation.

Does LL-37 help with chronic infections?

Chronic infection accounts for LL-37 are among the more specific in the category — describing responses to recurring sinusitis, biofilm-associated conditions, and post-Lyme immune dysregulation where other interventions had limited success. The mechanism cited: LL-37 disrupts bacterial membranes, including those of bacteria sheltered in biofilms. Positive accounts describe reduced infection frequency and duration over 4–8 week protocols. Negative accounts predominantly come from users without confirmed biofilm-type infections.